Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination drug product** containing four active ingredients: povidone-iodine, bupivacaine, isopropyl alcohol, and dexamethasone. - **Povidone-iodine** is a topical antiseptic with broad-spectrum antimicrobial activity, commonly used to prevent or treat infection in wounds and as a surgical antiseptic[12][2][5]. Its mechanism is the slow release of free iodine, which penetrates microbial cell walls, oxidizing cell components and disrupting protein and nucleic acid structure, leading to cell death. - **Bupivacaine** is a long-acting amide-type local anesthetic used for local or regional anesthesia and analgesia in surgical procedures[1]. Its primary mechanism is the blockade of voltage-gated sodium channels in neuronal membranes, inhibiting initiation and propagation of nerve impulses and thus causing loss of sensation[1]. Additional effects may arise from prostaglandin E2 receptor subtype EP1 (PGE2EP1) binding, contributing to anti-inflammatory and analgesic actions. - **Isopropyl alcohol** is a rapidly acting topical antiseptic and disinfectant used pre-operatively for skin antisepsis. It denatures proteins and disrupts cell membranes, leading to rapid microbial cell death. It is widely used for its bactericidal and virucidal properties. - **Dexamethasone** is a potent synthetic glucocorticoid with anti-inflammatory, immunosuppressive, and antiemetic effects[6][3][11]. Mechanistically, it binds cytoplasmic glucocorticoid receptors, altering transcription of anti-inflammatory proteins and suppressing production of pro-inflammatory cytokines. This combination may be used in perioperative or procedural settings, especially where prevention of infection and management of pain and inflammation are required. No unique FDA-approved combination product with this exact set of ingredients was identified; the combination may be used in compounded formulations for specific surgical protocols (e.g., in kits for local infiltration or as part of perioperative wound management strategies)[7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + bupivacaine + isopropyl alcohol + dexamethasone.